TLNC — Talon Capital Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2073340 ·
Last close
$10.21
Market Cap
$262.18M
52W High
$11.30
52W Low
$9.91
ADV30
72,208
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,009,905 | 1,322,627 | 259,010,121 | 2,399,609 | 10,944,103 |
| Mar 2026 | 0 | — | -342,807 | 1,971,217 | 257,162,549 | 2,653,957 | 10,419,158 |
| Sep 2025 | 0 | — | -159,097 | 383,939 | 252,862,213 | 3,096,635 | 10,368,532 |
| Jun 2025 | — | — | — | — | 307,810 | 48,000 | 320,067 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-301,327
Investing CF
$82,657
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.09
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,551,478
Inventory
—
Receivables
$185,111
ST Investments
—
EBIT TTM
$-575,904
Pretax Income TTM
$2,355,156
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 1y)
Revenues vs Net Income (last 1y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | 255,100,876 | 10,328,702 | 244,772,174 | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$257,162,549
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CEPV | Cantor Equity Partners V, Inc. | $262.04M | $10.26 | — |
| OBA | Oxley Bridge Acquisition Ltd | $261.86M | $10.35 | — |
| AMAC | AMR Resources Acquisition Corp. | $261.73M | $9.80 | — |
| HCMA | HCM III ACQUISITION CORP. | $261.10M | $10.32 | — |
| DMAA | Drugs Made In America Acquisition Corp. | $263.40M | $10.85 | — |
News headlines (Yahoo Finance, 1h cache)
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-04-10 00:00 · Yahoo
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-01-13 01:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.